Current Opinion in Structural Biology is a prestigious international journal published by Elsevier in the United Kingdom, identified by the ISSN 0959-440X, which serves as a leading platform for disseminating high-level reviews in the field of structural biology. Released on a bimonthly basis, the journal focuses exclusively on synthesizing recent advances and offering critical perspectives on core topics such as protein structures, molecular interactions, and the assembly of biological macromolecules. As a non-open access publication indexed in the Science Citation Index, it maintains a high impact factor and is consistently ranked in the first or second quartile of the Chinese Academy of Sciences journal rankings, underscoring its significant standing within the biological sciences. The journal is renowned for its rigorous peer-review process and authoritative content, catering to a specialized audience of researchers and academics seeking to stay abreast of the latest theoretical and conceptual developments in the discipline. While its emphasis on comprehensive reviews rather than original experimental data makes it an essential resource for understanding the broader context of structural biology, it is important to note that the competitive nature of the review submission process and the subscription-based access model may limit its immediate reach for those primarily seeking to publish novel experimental findings or for readers without institutional access.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com